Goudard M, Regli P, Buffard Y, Gabriel B
Laboratoire de Botanique et Cryptogamie, Faculté de Pharmacie, Marseille, France.
Pathol Biol (Paris). 1988 Feb;36(2):139-43.
Terbinafine, a new antifungal agent derived from allylamine, effective by oral route, was tested against 32 different strains of Aspergilli to determine its in vitro efficiency compared with amphotericin B, 5-fluorocytosine and ketoconazole. Antifungal sensitivity was determine by the MIC method in liquid and solid mediums (Sabouraud, Casitone, YMA, YMB, YNB): with MIC between 0.005 and 5 micrograms/ml, whatever the species and the techniques, terbinafine is more efficient than amphotericin B, ketoconazole (0.5 to 100 micrograms/ml) and 5-FC (1-greater than 100 micrograms/ml).
特比萘芬是一种源自烯丙胺的新型抗真菌药物,口服有效。对32种不同的曲霉菌菌株进行了测试,以确定其与两性霉素B、5-氟胞嘧啶和酮康唑相比的体外疗效。通过在液体和固体培养基(沙氏培养基、酪蛋白胨培养基、酵母提取物麦芽汁琼脂培养基、酵母提取物麦芽汁肉汤培养基、酵母氮源培养基)中采用MIC法测定抗真菌敏感性:无论菌种和技术如何,MIC在0.005至5微克/毫升之间时,特比萘芬比两性霉素B、酮康唑(0.5至100微克/毫升)和5-氟胞嘧啶(1 - 大于100微克/毫升)更有效。